PD van Poelje, SC Potter, VC Chandramouli, … - Diabetes, 2006 - Am Diabetes Assoc Gluconeogenesis is increased in type 2 diabetes and contributes significantly to
fasting and postprandial hyperglycemia. We recently reported the discovery of
the first potent and selective inhibitors of fructose 1,6-bisphosphatase ... Cited by 16 - Related articles - BL Direct - All 5 versions
R Basu, P Shah, A Basu, B Norby, B Dicke, … - Diabetes, 2008 - Am Diabetes Assoc RESULTS—Glucose was clamped before and after therapy at ∼5 mmol/l, insulin
raised to ∼180 pmol/l, C-peptide suppressed with somatostatin, glucagon
replaced at ∼75 pg/ml, and glycerol maintained at ∼200 mmol/l to ensure ... Cited by 10 - Related articles - BL Direct - All 8 versions
- ►snmjournals.org P Iozzo, A Gastaldelli, MJ Jarvisalo, J Kiss, … - Journal of Nuclear Medicine, 2006 - Soc Nuclear Med The glucose analog 18 F-FDG is commonly used to quantify regional glucose uptake
in vivo. The aim of this study was to test whether the analysis of plasma 18
F-FDG kinetics could be used to estimate endogenous glucose production ... Cited by 9 - Related articles - BL Direct - All 3 versions
G Bock, E Chittilapilly, R Basu, G Toffolo, C … - Diabetes, 2007 - Am Diabetes Assoc RESULTS—Despite higher (P < 0.001) insulin and C-peptide concentrations and
visceral fat (P < 0.05), fasting EGP and glucose disposal did not differ between
IFG and NFG subjects, implying hepatic and extrahepatic insulin resistance. ... Cited by 7 - Related articles - BL Direct - All 5 versions
- ►edulife.com.br [PDF] J Radziuk, S Pye - Diabetologia, 2006 - Springer Abstract Aims/hypothesis: An increase in endogenous glucose production (EGP) is
a major contributor to fasting morning hyperglycaemia in type 2 diabetes. This
increase is dissipated with fasting, later in the day. To understand its ... Cited by 5 - Related articles - BL Direct - All 5 versions
CM Sena, C Barosa, E Nunes, R Seica, JG … - Diabetes and Metabolism, 2007 - Elsevier Plasma glucose, insulin and glucose tolerance were quantified in diabetic
Goto–Kakizaki (GK) rats (342 ± 45 g, n = 5) and compared with weight-matched
non-diabetic Wistars (307 ± 30 g, n = 8). Compared to Wistars, GK rats had ... Cited by 4 - Related articles - BL Direct - All 2 versions
FQ Nuttall, A Ngo, MC Gannon - Diabetes/Metabolism Reviews - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 3 - Related articles - All 3 versions
MS Winzell, CL Brand, N Wierup, UG … - Diabetologia, 2007 - Springer Abstract Aims/hypothesis Increased glucagon secretion predicts dete- rioration
of glucose tolerance, and high glucagon levels contribute to hyperglycaemia in
type 2 diabetes. Inhibition of glucagon action may therefore be a potential ... Cited by 2 - Related articles - BL Direct - All 6 versions
- ►192.35.79.232 [PDF] JP Kirwan, TPJ Solomon, DM Wojta, MA … - American Journal of Physiology- Endocrinology And …, 2009 - Am Physiological Soc The objectives of this study were to determine whether 1) the improvement in
insulin action induced by short-term exercise training in patients with type 2
diabetes is due to an improvement in insulin sensitivity, an improvement in ... Cited by 2 - Related articles - All 7 versions
H Yan, W Gu, J Yang, V Bi, Y Shen, E Lee, KA … - Journal of Pharmacology and Experimental …, 2009 - ASPET Antagonizing the glucagon signaling pathway represents an attractive therapeutic
approach for reducing excess hepatic glucose production in patients with type 2
diabetes. Despite extensive efforts, there is currently no human ... Cited by 2 - Related articles - All 4 versions
